Loading...
Cost-Effectiveness of the 21-Gene Recurrence Score Assay in the Context of Multifactorial Decision Making to Guide Chemotherapy for Early-Stage Breast Cancer
PURPOSE: New evidence is available regarding the utility of the 21-gene Recurrence Score (RS) assay in guiding chemotherapy use for node-negative, estrogen receptor–positive breast cancer. We applied this evidence in a decision-analytic model to reevaluate the cost-effectiveness of the assay. METHOD...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3743447/ https://ncbi.nlm.nih.gov/pubmed/22975761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gim.2012.119 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|